,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af,gnomad_popmax_exome_af,gnomad_popmax_genome_af
0,1,M,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_1), 1-4, ELM",,,,,,,,,,,,,
1,2,K,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_1), 1-4, ELM",,,,,,,,,,,,,
2,3,L,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_1), 1-4, ELM|PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 3-9, ELM",,,,,,,,,,,,,
3,4,Q,,,,,,,,,,,,"N-degron (DEG_Nend_UBRbox_1), 1-4, ELM|PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 3-9, ELM",,,,,,,,,,,,,
4,5,A,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 3-9, ELM",,,,,,,,,,,,,
5,6,V,M,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 3-9, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929544-929544","hg19,19:g.929544G>A",0.136,,,,,,
6,7,M,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 3-9, ELM",,,,,,,,,,,,,
7,8,E,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 3-9, ELM",,,,,,,,,,,,,
8,9,T,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 3-9, ELM",,,,,,,,,,,,,
9,10,L,,,,,,,,,,,,,,,,,,,,,,,,,
10,11,L,,,,,,,,,,,,,,,,,,,,,,,,,
11,12,Q,,,,,,,,,,,,,,,,,,,,,,,,,
12,13,R,,,,,,,,,,,,,,,,,,,,,,,,,
13,14,Q,,,,,,,,,,,,,,,,,,,,,,,,,
14,15,Q,,,,,,,,,,,,,,,,,,,,,,,,,
15,16,R,,,,,,,,,,,,,,,,,,,,,,,,,
16,17,A,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 17-20, ELM",,,,,,,,,,,,,
17,18,R,C,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 17-20, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929580-929580","hg19,19:g.929580C>T",0.074,,,0.0000082481029363,,,
18,19,Q,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 17-20, ELM",,,,,,,,,,,,,
19,20,E,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 17-20, ELM",,,,,,,,,,,,,
20,21,L,,,,,,,,,,,,,,,,,,,,,,,,,
21,22,E,D,,,,,,,,,,,,,COSMIC,,,"hg38,19:929594-929594","hg38,19:g.929594G>T",0.140,breast,"carcinoma, ductal_carcinoma",,,,
22,23,A,,,,,,,,,,,,,,,,,,,,,,,,,
23,24,R,Q,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929599-929599","hg19,19:g.929599G>A",0.071,,,0.0000330011220381,,,
24,24,R,W,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929598-929598","hg19,19:g.929598C>T",0.086,,,0.0000741265422439,,,
25,25,Q,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 25-31, ELM",,,,,,,,,,,,,
26,26,Q,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 25-31, ELM|SH3 ligand (LIG_SH3_3), 26-32, ELM",,,,,,,,,,,,,
27,27,L,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 25-31, ELM|SH3 ligand (LIG_SH3_3), 26-32, ELM",,,,,,,,,,,,,
28,28,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 25-31, ELM|SH3 ligand (LIG_SH3_3), 26-32, ELM",,,,,,,,,,,,,
29,29,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 25-31, ELM|SH3 ligand (LIG_SH3_3), 26-32, ELM|SH3 ligand (LIG_SH3_3), 29-35, ELM",,,,,,,,,,,,,
30,30,D,N,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 25-31, ELM|SH3 ligand (LIG_SH3_3), 26-32, ELM|SH3 ligand (LIG_SH3_3), 29-35, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929616-929616","hg19,19:g.929616G>A",0.040,,,0.0000660512888258,,,
31,31,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 25-31, ELM|SH3 ligand (LIG_SH3_3), 26-32, ELM|SH3 ligand (LIG_SH3_3), 29-35, ELM",,,,,,,,,,,,,
32,32,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 26-32, ELM|SH3 ligand (LIG_SH3_3), 29-35, ELM",,,,,,,,,,,,,
33,33,A,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 29-35, ELM",,,,,,,,,,,,,
34,34,A,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 29-35, ELM",,,,,,,,,,,,,
35,35,P,R,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 29-35, ELM",,COSMIC,,,"hg38,19:929632-929632","hg38,19:g.929632C>G",0.015,liver,"other, neoplasm",,,,
36,36,P,,,,,,,,,,,,,,,,,,,,,,,,,
37,37,G,S,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
38,38,R,W,,,,,,,,,,,,,"cBioPortal,Manual annotations from clinvar.csv",pptc_2019,Mixed Cancer Types,"hg19,19:929640-929640","hg19,19:g.929640C>T",0.067,,,0.0000705826993961,0.0001280983795555,,
39,39,A,,,,,,,,,,,,,,,,,,,,,,,,,
40,40,R,,,,,,,,,,,,,,,,,,,,,,,,,
41,41,A,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 41-49, ELM",,,,,,,,,,,,,
42,42,A,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 41-49, ELM",,,,,,,,,,,,,
43,43,P,S,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 41-49, ELM",,"cBioPortal,Manual annotations from clinvar.csv",pptc_2019,Mixed Cancer Types,"hg19,19:929655-929655","hg19,19:g.929655C>T",0.029,,,0.0001910098051700,0.0000960430272762,,
44,43,P,T,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 41-49, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929655-929655","hg19,19:g.929655C>A",0.032,,,0.0000000000000000,,,
45,44,D,N,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 41-49, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
46,45,E,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 41-49, ELM",,,,,,,,,,,,,
47,46,D,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 41-49, ELM",,,,,,,,,,,,,
48,47,R,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 41-49, ELM",,,,,,,,,,,,,
49,48,E,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 41-49, ELM",,,,,,,,,,,,,
50,49,P,S,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 41-49, ELM",,COSMIC,,,"hg38,19:929673-929673","hg38,19:g.929673C>T",0.063,"skin, upper_arm",malignant_melanoma,,,,
51,50,E,,,,,,,,,,,,,,,,,,,,,,,,,
52,51,S,,,,,,,,,,,,,,,,,,,,,,,,,
53,52,A,V,,,,,,,,,,,,,COSMIC,,,"hg38,19:929683-929683","hg38,19:g.929683C>T",0.039,stomach,carcinoma,,,,
54,53,R,Q,,,,,,,,,,,,,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,19:929686-929686","hg38,19:g.929686G>A",0.031,stomach,"carcinoma, signet_ring_adenocarcinoma",0.0000963251938545,0.0001279099513942,,
55,54,M,,,,,,,,,,,,,,,,,,,,,,,,,
56,55,Q,,,,,,,,,,,,,,,,,,,,,,,,,
57,56,R,W,,,,,,,,,,,,,COSMIC,,,"hg38,19:929694-929694","hg38,19:g.929694C>T",0.117,thyroid,carcinoma,0.0000293689206334,,,
58,57,A,,,,,,,,,,,,,,,,,,,,,,,,,
59,58,Q,,,,,,,,,,,,"VCP (P97, TERA) N-terminal domain binding motifs (LIG_VCP_VIM_2), 58-67, ELM",,,,,,,,,,,,,
60,59,M,,,,,,,,,,,,"VCP (P97, TERA) N-terminal domain binding motifs (LIG_VCP_VIM_2), 58-67, ELM",,,,,,,,,,,,,
61,60,A,V,,,,,,,,,,,"VCP (P97, TERA) N-terminal domain binding motifs (LIG_VCP_VIM_2), 58-67, ELM",,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,19:929707-929707","hg19,19:g.929707C>T",0.239,,,,,,
62,61,A,T,,,,,,,,,,,"VCP (P97, TERA) N-terminal domain binding motifs (LIG_VCP_VIM_2), 58-67, ELM",,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018",Head and Neck Squamous Cell Carcinoma,"hg19,19:929709-929709, hg38,19:929709-929709","hg19,19:g.929709G>A, hg38,19:g.929709G>A",0.143,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",0.0000176010889207,,,
63,61,A,V,,,,,,,,,,,"VCP (P97, TERA) N-terminal domain binding motifs (LIG_VCP_VIM_2), 58-67, ELM",,COSMIC,,,"hg38,19:929710-929710","hg38,19:g.929710C>T",0.182,large_intestine,"carcinoma, adenocarcinoma",,,,
64,62,L,,,,,,,,,,,,"VCP (P97, TERA) N-terminal domain binding motifs (LIG_VCP_VIM_2), 58-67, ELM",,,,,,,,,,,,,
65,63,A,,,,,,,,,,,,"VCP (P97, TERA) N-terminal domain binding motifs (LIG_VCP_VIM_2), 58-67, ELM",,,,,,,,,,,,,
66,64,A,,,,,,,,,,,,"VCP (P97, TERA) N-terminal domain binding motifs (LIG_VCP_VIM_2), 58-67, ELM",,,,,,,,,,,,,
67,65,M,,,,,,,,,,,,"VCP (P97, TERA) N-terminal domain binding motifs (LIG_VCP_VIM_2), 58-67, ELM",,,,,,,,,,,,,
68,66,R,Q,,,,,,,,,,,"VCP (P97, TERA) N-terminal domain binding motifs (LIG_VCP_VIM_2), 58-67, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,19:929725-929726, hg38,19:929725-929726","hg19,19:g.929725_929726delinsAA, hg38,19:g.929725_929726delinsAA",,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,,,
69,67,A,G,,,,,,,,,,,"VCP (P97, TERA) N-terminal domain binding motifs (LIG_VCP_VIM_2), 58-67, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929728-929728","hg19,19:g.929728C>G",0.151,,,,,,
70,67,A,V,,,,,,,,,,,"VCP (P97, TERA) N-terminal domain binding motifs (LIG_VCP_VIM_2), 58-67, ELM",,cBioPortal,angs_painter_2020,Angiosarcoma,"hg19,19:929728-929728","hg19,19:g.929728C>T",0.131,,,0.0000000000000000,,,
71,68,A,,,,,,,,,,,,,,,,,,,,,,,,,
72,69,A,V,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929734-929734","hg19,19:g.929734C>T",0.119,,,,,,
73,70,A,T,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929736-929736","hg19,19:g.929736G>A",0.177,,,,,,
74,70,A,V,,,,,,,,,,,,,COSMIC,,,"hg38,19:929737-929737","hg38,19:g.929737C>T",0.216,"large_intestine, colon, descending","carcinoma, adenocarcinoma",0.0000501366222958,,,
75,71,G,,,,,,,,,,,,,,,,,,,,,,,,,
76,72,L,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 72-78, ELM",,,,,,,,,,,,,
77,73,G,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 72-78, ELM",,,,,,,,,,,,,
78,74,H,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 74-79, ELM|SH3 ligand (LIG_SH3_3), 72-78, ELM",,,,,,,,,,,,,
79,75,P,S,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 74-79, ELM|SH3 ligand (LIG_SH3_3), 72-78, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929751-929751","hg19,19:g.929751C>T",0.082,,,,,,
80,76,A,T,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 74-79, ELM|SH3 ligand (LIG_SH3_3), 72-78, ELM",,COSMIC,,,"hg38,19:929754-929754","hg38,19:g.929754G>A",0.010,thyroid,carcinoma,,,,
81,76,A,V,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 74-79, ELM|SH3 ligand (LIG_SH3_3), 72-78, ELM",,COSMIC,,,"hg38,19:929755-929755","hg38,19:g.929755C>T",0.068,thyroid,carcinoma,0.0000000000000000,,,
82,77,S,,P,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 74-79, ELM|SH3 ligand (LIG_SH3_3), 72-78, ELM",,,,,,,,,,,,,
83,78,P,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 78-82, ELM|WW domain ligands (DOC_WW_Pin1_4), 74-79, ELM|SH3 ligand (LIG_SH3_3), 72-78, ELM",,,,,,,,,,,,,
84,79,G,S,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 78-82, ELM|WW domain ligands (DOC_WW_Pin1_4), 74-79, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
85,80,G,S,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 78-82, ELM",,COSMIC,,,"hg38,19:929766-929766","hg38,19:g.929766G>A",0.080,"large_intestine, colon","carcinoma, adenocarcinoma",0.0001184678162433,0.0000638732754216,,
86,81,S,,P,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 78-82, ELM",,,,,,,,,,,,,
87,82,E,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 78-82, ELM",,,,,,,,,,,,,
88,83,D,,,,,,,,,,,,,,,,,,,,,,,,,
89,84,G,,,,,,,,,,,,,,,,,,,,,,,,,
90,85,P,,,,,,,,,,,,,,,,,,,,,,,,,
91,86,P,L,,,,,,,,,,,,,COSMIC,,,"hg38,19:929785-929785","hg38,19:g.929785C>T",0.027,stomach,"carcinoma, diffuse_adenocarcinoma",0.0000201946766832,,,
92,86,P,S,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
93,87,G,C,,,,,,,,,,,,,cBioPortal,"metastatic_solid_tumors_mich_2017, prad_p1000, prad_su2c_2019","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,19:929787-929787","hg19,19:g.929787G>T",0.111,,,,,,
94,88,S,L,P,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 88-91, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
95,89,E,D,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 88-91, ELM",,COSMIC,,,"hg38,19:929795-929795","hg38,19:g.929795G>C, hg38,19:g.929795G>T",0.106,"thyroid, upper_aerodigestive_tract, mouth",carcinoma,,,,
96,89,E,K,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 88-91, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929793-929793","hg19,19:g.929793G>A",0.083,,,,,,
97,90,E,K,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 88-91, ELM",,COSMIC,,,"hg38,19:929796-929796","hg38,19:g.929796G>A",0.134,"central_nervous_system, brain","glioma, gliomatosis_cerebri",0.0000067959713482,,,
98,91,E,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 88-91, ELM",,,,,,,,,,,,,
99,92,D,,,,,,,,,,,,,,,,,,,,,,,,,
100,93,A,T,,,,,,,,,,,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:929805-929805, hg38,19:929805-929805","hg19,19:g.929805G>A, hg38,19:g.929805G>A",0.016,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,0.0000481788398535,,,
101,94,A,,,,,,,,,,,,,,,,,,,,,,,,,
102,95,R,Q,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 95-100, ELM",,cBioPortal,lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,19:929812-929813",,,,,,,,
103,95,R,W,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 95-100, ELM",,"cBioPortal,COSMIC",rectal_msk_2022,Bowel,"hg19,19:929811-929811, hg38,19:929811-929811","hg19,19:g.929811C>T, hg38,19:g.929811C>T",0.131,large_intestine,"carcinoma, adenocarcinoma",0.0000206148729437,0.0000639795265515,,
104,96,E,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 95-100, ELM|SH3 ligand (LIG_SH3_3), 96-102, ELM",,,,,,,,,,,,,
105,97,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 95-100, ELM|SH3 ligand (LIG_SH3_3), 96-102, ELM",,,,,,,,,,,,,
106,98,T,I,P,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 95-100, ELM|WW domain ligands (DOC_WW_Pin1_4), 98-103, ELM|SH3 ligand (LIG_SH3_3), 96-102, ELM",,"cBioPortal,COSMIC","thca_tcga, thca_tcga_pub",Papillary Thyroid Cancer,"hg19,19:929821-929821, hg38,19:929821-929821","hg19,19:g.929821C>T, hg38,19:g.929821C>T",0.017,thyroid,carcinoma,,,,
107,99,P,L,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 95-100, ELM|WW domain ligands (DOC_WW_Pin1_4), 98-103, ELM|SH3 ligand (LIG_SH3_2), 99-104, ELM|SH3 ligand (LIG_SH3_3), 96-102, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
108,100,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 95-100, ELM|WW domain ligands (DOC_WW_Pin1_4), 98-103, ELM|SH3 ligand (LIG_SH3_2), 99-104, ELM|SH3 ligand (LIG_SH3_3), 96-102, ELM",,,,,,,,,,,,,
109,101,S,L,P,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 98-103, ELM|SH3 ligand (LIG_SH3_2), 99-104, ELM|SH3 ligand (LIG_SH3_3), 96-102, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,19:929830-929830, hg38,19:929830-929830","hg19,19:g.929830C>T, hg38,19:g.929830C>T",0.049,breast,carcinoma,,,,
110,102,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 98-103, ELM|SH3 ligand (LIG_SH3_2), 99-104, ELM|SH3 ligand (LIG_SH3_3), 96-102, ELM",,,,,,,,,,,,,
111,103,G,R,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 98-103, ELM|SH3 ligand (LIG_SH3_2), 99-104, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929835-929835","hg19,19:g.929835G>A",0.051,,,0.0000476371951220,0.0000319652218386,,
112,104,R,Q,,,,,,,,,,,"SH3 ligand (LIG_SH3_2), 99-104, ELM",,COSMIC,,,"hg38,19:929839-929839","hg38,19:g.929839G>A",0.069,oesophagus,"carcinoma, squamous_cell_carcinoma",0.0000067876681645,,,
113,105,G,,,,,,,,,,,,,,,,,,,,,,,,,
114,106,R,G,,,,,,,,,,,,,COSMIC,,,"hg38,19:929844-929844","hg38,19:g.929844A>G",0.012,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",0.0016332782130174,0.0014367816091954,,
115,107,E,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 107-115, ELM",,,,,,,,,,,,,
116,108,G,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 107-115, ELM",,,,,,,,,,,,,
117,109,P,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 109-112, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 107-115, ELM",,,,,,,,,,,,,
118,110,G,,,,,,,,,,,,"TRAF2 binding site (LIG_TRAF2_1), 109-112, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 107-115, ELM",,,,,,,,,,,,,
119,111,E,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 111-118, ELM|TRAF2 binding site (LIG_TRAF2_1), 109-112, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 107-115, ELM",,,,,,,,,,,,,
120,112,E,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 111-118, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 112-118, ELM|TRAF2 binding site (LIG_TRAF2_1), 109-112, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 107-115, ELM",,,,,,,,,,,,,
121,113,H,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 111-118, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 112-118, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 107-115, ELM",,,,,,,,,,,,,
122,114,F,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 111-118, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 112-118, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 107-115, ELM",,,,,,,,,,,,,
123,115,E,K,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 111-118, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 112-118, ELM|Motif which binds to the MATH domain of the TRAF6 K63 E3 ligase (LIG_TRAF6_MATH_1), 107-115, ELM",,COSMIC,,,"hg38,19:929871-929871","hg38,19:g.929871G>A",0.030,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,,,
124,116,D,Y,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 111-118, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 112-118, ELM",,"cBioPortal,COSMIC",sarc_tcga_pan_can_atlas_2018,Soft Tissue,"hg19,19:929874-929874, hg38,19:929874-929874","hg19,19:g.929874G>T, hg38,19:g.929874G>T",0.113,soft_tissue,sarcoma,,,,
125,117,M,,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 111-118, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 112-118, ELM",,,,,,,,,,,,,
126,118,A,D,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 111-118, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 112-118, ELM",,cBioPortal,mixed_pipseq_2017,Mixed Cancer Types,"hg19,19:929881-929881","hg19,19:g.929881C>A",0.098,,,,,,
127,118,A,T,,,,,,,,,,,"Atg8 protein family ligands (LIG_LIR_Gen_1), 111-118, ELM|Atg8 protein family ligands (LIG_LIR_Gen_1), 112-118, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:929880-929880","hg19,19:g.929880G>A",0.090,,,,,,
128,119,S,,P,,,,,,,,,,,,,,,,,,,,,,,
129,120,D,,,,,,,,,,,,,,,,,,,,,,,,,
130,121,E,K,,,,,,,,,,,,,"cBioPortal,Manual annotations from clinvar.csv",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:929889-929889","hg19,19:g.929889G>A",0.088,,,0.0000346620450607,0.0000956754688098,,
131,122,D,,,,,,,,,,,,,,,,,,,,,,,,,
132,123,M,V,,,,,,,,,,,,,COSMIC,,,"hg38,19:929895-929895","hg38,19:g.929895A>G",0.064,"soft_tissue, striated_muscle","rhabdomyosarcoma, alveolar",0.0000138607823026,0.0000318918229366,,
133,124,K,,,,,,,,,,,,,,,,,,,,,,,,,
134,125,P,L,,,,,,,,,,,,,cBioPortal,bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:932423-932423","hg19,19:g.932423C>T",0.033,,,,,,
135,126,K,N,,,,,,,,,,,,,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,19:932427-932427","hg19,19:g.932427A>T",0.085,,,,,,
136,127,W,,,,,,,,,,,,,,,,,,,,,,,,,
137,128,E,,,,,,,,,,,,,,,,,,,,,,,,,
138,129,E,,,,,,,,,,,,,,,,,,,,,,,,,
139,130,E,,,,,,,,,,,,,,,,,,,,,,,,,
140,131,E,,,,,,,,,,,,,,,,,,,,,,,,,
141,132,M,,,,,,,,,,,,,,,,,,,,,,,,,
142,133,E,,,,,,,,,,,,,,,,,,,,,,,,,
143,134,E,,,,,,,,,,,,,,,,,,,,,,,,,
144,135,D,,,,,,,,,,,,,,,,,,,,,,,,,
145,136,L,,,,,,,,,,,,,,,,,,,,,,,,,
146,137,G,R,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
147,138,E,,,,,,,,,,,,,,,,,,,,,,,,,
148,139,D,,,,,,,,,,,,,,,,,,,,,,,,,
149,140,E,,,,,,,,,,,,,,,,,,,,,,,,,
150,141,E,D,,,,,,,,,,,,,"cBioPortal,COSMIC","lihc_tcga, lihc_tcga_pan_can_atlas_2018",Hepatocellular Carcinoma,"hg19,19:932472-932472, hg38,19:932472-932472","hg19,19:g.932472G>C, hg38,19:g.932472G>C",0.040,liver,"carcinoma, hepatocellular_carcinoma",,,,
151,142,E,,,,,,,,,,,,,,,,,,,,,,,,,
152,143,E,G,,,,,,,,,,,,,cBioPortal,lihc_tcga,Hepatocellular Carcinoma,"hg19,19:932477-932477","hg19,19:g.932477A>G",0.044,,,,,,
153,144,E,,,,,,,,,,,,,,,,,,,,,,,,,
154,145,E,D,,,,,,,,,,,,,cBioPortal,tgct_tcga,Non-Seminomatous Germ Cell Tumor,"hg19,19:932484-932484","hg19,19:g.932484G>T",0.061,,,,,,
155,146,D,,,,,,,,,,,,,,,,,,,,,,,,,
156,147,Y,,,,,,,,,,,,,,,,,,,,,,,,,
157,148,E,,,,,,,,,,,,,,,,,,,,,,,,,
158,149,D,E,,,,,,,,,,,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:932496-932496","hg19,19:g.932496T>G",0.078,,,0.0000282689507979,0.0000653253200941,,
159,150,E,,,,,,,,,,,,,,,,,,,,,,,,,
160,151,E,,,,,,,,,,,,,,,,,,,,,,,,,
161,152,E,Q,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:932503-932503","hg19,19:g.932503G>C",0.082,,,0.0000183123351890,0.0001274859765426,,
162,153,E,,,,,,,,,,,,,,,,,,,,,,,,,
163,154,E,,,,,,,,,,,,,,,,,,,,,,,,,
164,155,D,E,,,,,,,,,,,,,COSMIC,,,"hg38,19:932514-932514","hg38,19:g.932514C>A",0.020,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",0.0000000000000000,,,
165,156,E,,,,,,,,,,,,,,,,,,,,,,,,,
166,157,E,,,,,,,,,,,,,,,,,,,,,,,,,
167,158,G,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 158-164, ELM",,,,,,,,,,,,,
168,159,L,,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 159-162, ELM|SH3 ligand (LIG_SH3_3), 158-164, ELM",,,,,,,,,,,,,
169,160,G,,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 159-162, ELM|SH3 ligand (LIG_SH3_3), 158-164, ELM",,,,,,,,,,,,,
170,161,P,L,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 159-162, ELM|SH3 ligand (LIG_SH3_3), 158-164, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:932531-932531, hg38,19:932531-932531","hg19,19:g.932531C>T, hg38,19:g.932531C>T",0.055,skin,"carcinoma, basal_cell_carcinoma",,,,
171,161,P,S,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 159-162, ELM|SH3 ligand (LIG_SH3_3), 158-164, ELM",,cBioPortal,bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:932530-932530","hg19,19:g.932530C>T",0.054,,,,,,
172,162,P,,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 159-162, ELM|SH3 ligand (LIG_SH3_3), 158-164, ELM",,,,,,,,,,,,,
173,163,G,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 158-164, ELM",,,,,,,,,,,,,
174,164,P,S,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 158-164, ELM",,"cBioPortal,COSMIC","kirp_tcga, kirp_tcga_pan_can_atlas_2018",Papillary Renal Cell Carcinoma,"hg19,19:932539-932539, hg38,19:932539-932539","hg19,19:g.932539C>T, hg38,19:g.932539C>T",0.054,kidney,"carcinoma, papillary_renal_cell_carcinoma",,,,
175,165,A,D,,,,,,,,,,,,,COSMIC,,,"hg38,19:932543-932543","hg38,19:g.932543C>A",0.066,thyroid,carcinoma,,,,
176,166,S,,,,,,,,,,,,,,,,,,,,,,,,,
177,167,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 167-173, ELM",,,,,,,,,,,,,
178,168,G,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 167-173, ELM",,,,,,,,,,,,,
179,169,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 167-173, ELM",,,,,,,,,,,,,
180,170,T,M,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 167-173, ELM",,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,19:932558-932558","hg19,19:g.932558C>T",0.099,,,0.0000183012755989,0.0000637755102041,,
181,171,A,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 167-173, ELM",,,,,,,,,,,,,
182,172,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 167-173, ELM",,,,,,,,,,,,,
183,173,F,Y,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 167-173, ELM",,COSMIC,,,"hg38,19:932567-932567","hg38,19:g.932567T>A",0.111,thyroid,carcinoma,,,,
184,174,P,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ELM",,,,,,,,,,,,,
185,175,R,G,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ELM",,cBioPortal,"acc_tcga, acc_tcga_pan_can_atlas_2018",Adrenocortical Carcinoma,"hg19,19:932572-932572","hg19,19:g.932572C>G",0.114,,,,,,
186,175,R,Q,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ELM",,"cBioPortal,COSMIC",metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,19:932573-932573, hg38,19:932573-932573","hg19,19:g.932573G>A, hg38,19:g.932573G>A",0.097,"skin, lower_extremity","carcinoma, Merkel_cell_carcinoma",0.0000000000000000,,,
187,176,K,R,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 174-176, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:932576-932576, hg38,19:932576-932576","hg19,19:g.932576A>G, hg38,19:g.932576A>G",0.068,pancreas,"carcinoma, ductal_carcinoma",,,,
188,177,A,G,,,,,,,,,,,,,"cBioPortal,COSMIC","mixed_allen_2018, prad_fhcrc","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,19:932579-932579, hg38,19:932579-932579","hg19,19:g.932579C>G, hg38,19:g.932579C>G",0.054,prostate,"carcinoma, adenocarcinoma",,,,
189,178,Q,,,,,,,,,,,,,,,,,,,,,,,,,
190,179,P,S,,,,,,,,,,,"EVH1  ligands (LIG_EVH1_2), 179-183, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,19:932584-932584, hg38,19:932584-932584","hg19,19:g.932584C>T, hg38,19:g.932584C>T",0.080,"large_intestine, caecum","carcinoma, adenocarcinoma",,,,
191,180,P,,,,,,,,,,,,"EVH1  ligands (LIG_EVH1_2), 179-183, ELM",,,,,,,,,,,,,
192,181,Q,,,,,,,,,,,,"EVH1  ligands (LIG_EVH1_2), 179-183, ELM",,,,,,,,,,,,,
193,182,A,G,,,,,,,,,,,"EVH1  ligands (LIG_EVH1_2), 179-183, ELM",,COSMIC,,,"hg38,19:932594-932594","hg38,19:g.932594C>G",0.034,"large_intestine, colon","carcinoma, adenocarcinoma",,,,
194,183,F,,,,,,,,,,,,"EVH1  ligands (LIG_EVH1_2), 179-183, ELM",,,,,,,,,,,,,
195,184,R,C,,,,,,,,,,,"Integrin RGD-type binding sites (LIG_Integrin_RGD_1), 184-186, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:932599-932599","hg19,19:g.932599C>T",0.122,,,0.0000683900971139,,,
196,185,G,,,,,,,,,,,,"Integrin RGD-type binding sites (LIG_Integrin_RGD_1), 184-186, ELM",,,,,,,,,,,,,
197,186,D,,,,,,,,,,,,"Integrin RGD-type binding sites (LIG_Integrin_RGD_1), 184-186, ELM",,,,,,,,,,,,,
198,187,G,,,,,,,,,,,,,,,,,,,,,,,,,
199,188,V,,,,,,,,,,,,,,,,,,,,,,,,,
200,189,P,,,,,,,,,,,,,,,,,,,,,,,,,
201,190,R,,,,,,,,,,,,"MAD2 binding motif (LIG_MAD2), 190-198, ELM",,,,,,,,,,,,,
202,191,V,,,,,,,,,,,,"MAD2 binding motif (LIG_MAD2), 190-198, ELM",,,,,,,,,,,,,
203,192,L,,,,,,,,,,,,"MAD2 binding motif (LIG_MAD2), 190-198, ELM",,,,,,,,,,,,,
204,193,G,,,,,,,,,,,,"MAD2 binding motif (LIG_MAD2), 190-198, ELM",,,,,,,,,,,,,
205,194,G,,,,,,,,,,,,"MAD2 binding motif (LIG_MAD2), 190-198, ELM",,,,,,,,,,,,,
206,195,Q,H,,,,,,,,,,,"MAD2 binding motif (LIG_MAD2), 190-198, ELM",,COSMIC,,,"hg38,19:932634-932634","hg38,19:g.932634G>T",0.042,liver,"other, neoplasm",,,,
207,196,E,,,,,,,,,,,,"MAD2 binding motif (LIG_MAD2), 190-198, ELM",,,,,,,,,,,,,
208,197,R,Q,,,,,,,,,,,"MAD2 binding motif (LIG_MAD2), 190-198, ELM",,cBioPortal,brca_mbcproject_2022,Invasive Breast Carcinoma,"hg19,19:932639-932639","hg19,19:g.932639G>A",0.128,,,0.0001137621915149,0.0001912777352716,,
209,197,R,W,,,,,,,,,,,"MAD2 binding motif (LIG_MAD2), 190-198, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,19:932638-932638","hg38,19:g.932638C>T",0.182,breast,"carcinoma, ductal_carcinoma",0.0000076664775602,,,
210,198,P,,,,,,,,,,,,"MAD2 binding motif (LIG_MAD2), 190-198, ELM",,,,,,,,,,,,,
211,199,G,R,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 199-205, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:932644-932644","hg19,19:g.932644G>A",0.110,,,,,,
212,199,G,W,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 199-205, ELM",,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,19:932644-932644","hg19,19:g.932644G>T",0.091,,,,,,
213,200,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 199-205, ELM",,,,,,,,,,,,,
214,201,G,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 199-205, ELM",,,,,,,,,,,,,
215,202,P,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 199-205, ELM",,,,,,,,,,,,,
216,203,A,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 199-205, ELM",,,,,,,,,,,,,
217,204,H,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 199-205, ELM",,,,,,,,,,,,,
218,205,P,S,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 199-205, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
219,206,G,R,,,,,,,,,,,,,COSMIC,,,"hg38,19:932665-932665","hg38,19:g.932665G>A",0.060,pancreas,carcinoma,0.0000144154533660,,,
220,207,G,R,,,,,,,,,,,,,COSMIC,,,"hg38,19:932668-932668","hg38,19:g.932668G>A",0.135,"skin, trunk","malignant_melanoma, superficial_spreading",0.0000000000000000,,,
221,208,A,P,,,,,,,,,,,,,cBioPortal,gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,19:932671-932671","hg19,19:g.932671G>C",0.047,,,,,,
222,209,A,,,,,,,,,,,,,,,,,,,,,,,,,
223,210,H,,,,,,,,,,,,,,,,,,,,,,,,,
224,211,V,,,,,,,,,,,,,,,,,,,,,,,,,
225,212,A,V,,,,,,,,,,,,,"cBioPortal,COSMIC",stad_pfizer_uhongkong,Stomach Adenocarcinoma,"hg19,19:932684-932684, hg38,19:932684-932684","hg19,19:g.932684C>T, hg38,19:g.932684C>T",0.003,stomach,"carcinoma, intestinal_adenocarcinoma",0.0000071130838064,,,
226,213,P,,,,,,,,,,,,"MYND domain binding motif. (LIG_MYND_1), 213-217, ELM",,,,,,,,,,,,,
227,214,Q,,,,,,,,,,,,"MYND domain binding motif. (LIG_MYND_1), 213-217, ELM",,,,,,,,,,,,,
228,215,L,,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 215-218, ELM|MYND domain binding motif. (LIG_MYND_1), 213-217, ELM",,,,,,,,,,,,,
229,216,Q,,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 215-218, ELM|MYND domain binding motif. (LIG_MYND_1), 213-217, ELM",,,,,,,,,,,,,
230,217,P,,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 215-218, ELM|MYND domain binding motif. (LIG_MYND_1), 213-217, ELM",,,,,,,,,,,,,
231,218,P,,,,,,,,,,,,"Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 215-218, ELM",,,,,,,,,,,,,
232,219,D,,,,,,,,,,,,,,,,,,,,,,,,,
233,220,H,Q,,,,,,,,,,,,,COSMIC,,,"hg38,19:932709-932709","hg38,19:g.932709C>A",0.109,liver,"other, neoplasm",,,,
234,221,G,,,,,,,,,,,,,,,,,,,,,,,,,
235,222,D,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 222-228, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 222-229, ELM",,,,,,,,,,,,,
236,223,W,R,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 222-228, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 222-229, ELM",,"cBioPortal,COSMIC",kirp_tcga_pan_can_atlas_2018,Papillary Renal Cell Carcinoma,"hg19,19:932716-932716, hg38,19:932716-932716","hg19,19:g.932716T>C, hg38,19:g.932716T>C",0.324,kidney,"carcinoma, papillary_renal_cell_carcinoma",,,,
237,224,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 222-228, ELM|TRAF2 binding site (LIG_TRAF2_1), 224-227, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 222-229, ELM",,,,,,,,,,,,,
238,225,Y,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 222-228, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 225-229, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 225-228, ELM|TRAF2 binding site (LIG_TRAF2_1), 224-227, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 222-229, ELM",,,,,,,,,,,,,
239,226,E,K,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 222-228, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 225-229, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 225-228, ELM|TRAF2 binding site (LIG_TRAF2_1), 224-227, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 222-229, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:932725-932725","hg19,19:g.932725G>A",0.233,,,,,,
240,227,E,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 222-228, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 225-229, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 225-228, ELM|TRAF2 binding site (LIG_TRAF2_1), 224-227, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 222-229, ELM",,,,,,,,,,,,,
241,228,Q,K,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_2), 222-228, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 225-229, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT3), 225-228, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 222-229, ELM",,COSMIC,,,"hg38,19:932731-932731","hg38,19:g.932731C>A",0.196,"skin, mucosal, female_genital_tract_(site_indeterminate)",malignant_melanoma,,,,
242,229,F,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAP1), 225-229, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain (LIG_deltaCOP1_diTrp_1), 222-229, ELM",,,,,,,,,,,,,
243,230,K,,,,,,,,,,,,,,,,,,,,,,,,,
244,231,Q,H,,,,,,,,,,,,,COSMIC,,,"hg38,19:932742-932742","hg38,19:g.932742G>T",0.214,thyroid,carcinoma,,,,
245,232,L,,,,,,,,,,,,,,,,,,,,,,,,,
246,233,Y,,,,,,,,,,,,,,,,,,,,,,,,,
247,234,E,K,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:960098-960098","hg19,19:g.960098G>A",0.544,,,0.0000119949141564,,,
248,235,L,,,,,,,,,,,,,,,,,,,,,,,,,
249,236,D,E,,,,,,,,,,,,,"cBioPortal,COSMIC",mds_mskcc_2020,Myelodysplastic Syndromes,"hg19,19:960106-960106, hg38,19:960106-960106","hg19,19:g.960106C>A, hg38,19:g.960106C>A",0.276,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",,,,
250,236,D,N,,,,,,,,,,,,,COSMIC,,,"hg38,19:960104-960104","hg38,19:g.960104G>A",0.477,oesophagus,"carcinoma, adenocarcinoma",0.0000079930939668,,,
251,237,G,W,,,,,,,,,,,,,"cBioPortal,COSMIC","hnsc_tcga_pan_can_atlas_2018, skcm_tcga_pan_can_atlas_2018","Cutaneous Melanoma, Head and Neck Squamous Cell Carcinoma","hg19,19:960107-960107, hg38,19:960107-960107","hg19,19:g.960107G>T, hg38,19:g.960107G>T",0.146,"skin, upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma, malignant_melanoma",,,,
252,238,D,,,,,,,,,,,,,,,,,,,,,,,,,
253,239,P,,,,,,,,,,,,,,,,,,,,,,,,,
254,240,K,,,,Ubq,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 240-242, ELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 240-242, ELM",,,,,,,,,,,,,
255,241,R,M,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 240-242, ELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 240-242, ELM",,COSMIC,,,"hg38,19:960120-960120","hg38,19:g.960120G>T",0.669,"upper_aerodigestive_tract, mouth",carcinoma,,,,
256,242,K,R,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 240-242, ELM|PCSK cleavage site (CLV_PCSK_PC1ET2_1), 240-242, ELM|PCSK cleavage site (CLV_PCSK_SKI1_1), 242-246, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
257,243,E,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 242-246, ELM",,,,,,,,,,,,,
258,244,F,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 242-246, ELM",,,,,,,,,,,,,
259,245,L,M,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 242-246, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:960131-960131, hg38,19:960131-960131","hg19,19:g.960131C>A, hg38,19:g.960131C>A",0.470,skin,malignant_melanoma,,,,
260,245,L,V,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 242-246, ELM",,"cBioPortal,COSMIC","lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,19:960131-960131, hg38,19:960131-960131","hg19,19:g.960131C>G, hg38,19:g.960131C>G",0.436,lung,"carcinoma, squamous_cell_carcinoma",,,,
261,246,D,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 242-246, ELM",,,,,,,,,,,,,
262,247,D,,,,,,,,,,,,,,,,,,,,,,,,,
263,248,L,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 248-254, ELM|WAVE regulatory complex (WRC) binding site motif (LIG_WRC_WIRS_1), 248-253, ELM",,,,,,,,,,,,,
264,249,F,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 248-254, ELM|WAVE regulatory complex (WRC) binding site motif (LIG_WRC_WIRS_1), 248-253, ELM",,,,,,,,,,,,,
265,250,S,N,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 248-254, ELM|WAVE regulatory complex (WRC) binding site motif (LIG_WRC_WIRS_1), 248-253, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:960147-960147, hg38,19:960147-960147","hg19,19:g.960147G>A, hg38,19:g.960147G>A",0.127,large_intestine,"carcinoma, adenocarcinoma",,,,
266,251,F,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 248-254, ELM|WAVE regulatory complex (WRC) binding site motif (LIG_WRC_WIRS_1), 248-253, ELM",,,,,,,,,,,,,
267,252,M,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 248-254, ELM|WAVE regulatory complex (WRC) binding site motif (LIG_WRC_WIRS_1), 248-253, ELM",,,,,,,,,,,,,
268,253,Q,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 248-254, ELM|WAVE regulatory complex (WRC) binding site motif (LIG_WRC_WIRS_1), 248-253, ELM",,,,,,,,,,,,,
269,254,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 254-256, ELM|WW domain ligands (DOC_WW_Pin1_4), 254-259, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 248-254, ELM",,,,,,,,,,,,,
270,255,R,Q,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 254-256, ELM|WW domain ligands (DOC_WW_Pin1_4), 254-259, ELM",,"cBioPortal,COSMIC",mel_dfci_2019,Melanoma,"hg19,19:960162-960162, hg38,19:960162-960162","hg19,19:g.960162G>A, hg38,19:g.960162G>A",0.393,breast,"carcinoma, HER-positive_carcinoma",,,,
271,256,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 254-256, ELM|WW domain ligands (DOC_WW_Pin1_4), 254-259, ELM",,,,,,,,,,,,,
272,257,T,A,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 254-259, ELM",,cBioPortal,panet_arcnet_2017,Pancreatic Neuroendocrine Tumor,"hg19,19:964250-964250","hg19,19:g.964250A>G",0.436,,,,,,
273,258,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 254-259, ELM",,,,,,,,,,,,,
274,259,V,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 254-259, ELM",,,,,,,,,,,,,
275,260,N,,,,,,,,,,,,,,,,,,,,,,,,,
276,261,R,C,,,,,,,,,,,,,COSMIC,,,"hg38,19:964262-964262","hg38,19:g.964262C>T",0.586,"skin, mucosal, nasopharynx",malignant_melanoma,,,,
277,261,R,H,,,,,,,,,,,,,"cBioPortal,COSMIC","ccle_broad_2019, difg_glass_2019, gbm_tcga, gbm_tcga_pub2013, thca_tcga_pan_can_atlas_2018","Diffuse Glioma, Glioblastoma Multiforme, Mixed Cancer Types, Papillary Thyroid Cancer","hg19,19:964263-964263, hg38,19:964263-964263","hg19,19:g.964263G>A, hg38,19:g.964263G>A",0.503,"skin, mucosal, anorectal, thyroid","carcinoma, malignant_melanoma",,,,
278,262,I,,,,,,,,,,,,,,,,,,,,,,,,,
279,263,P,H,,,,,,,,,,,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:964269-964269, hg38,19:964269-964269","hg19,19:g.964269C>A, hg38,19:g.964269C>A",0.952,skin,malignant_melanoma,,,,
280,264,I,M,,,,,,,,,,,,,"cBioPortal,COSMIC",escc_icgc,Esophageal Squamous Cell Carcinoma,"hg19,19:964273-964273, hg38,19:964273-964273","hg19,19:g.964273C>G, hg38,19:g.964273C>G",0.344,oesophagus,carcinoma,,,,
281,264,I,V,,,,,,,,,,,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,19:964271-964271, hg38,19:964271-964271","hg19,19:g.964271A>G, hg38,19:g.964271A>G",0.285,lung,"carcinoma, carcinoma, adenocarcinoma",,,,
282,265,M,,,,,,,,,,,,,,,,,,,,,,,,,
283,266,A,,,,,,,,,,,,,,,,,,,,,,,,,
284,267,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 267-271, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 267-274, ELM|MAPK docking motifs (DOC_MAPK_NFAT4_5), 267-275, ELM",,,,,,,,,,,,,
285,268,Q,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 267-271, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 267-274, ELM|MAPK docking motifs (DOC_MAPK_NFAT4_5), 267-275, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,,,,,,,,,,,,
286,269,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 267-271, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 267-274, ELM|MAPK docking motifs (DOC_MAPK_NFAT4_5), 267-275, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,,,,,,,,,,,,
287,270,L,I,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 267-271, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 267-274, ELM|MAPK docking motifs (DOC_MAPK_NFAT4_5), 267-275, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:964289-964289, hg38,19:964289-964289","hg19,19:g.964289C>A, hg38,19:g.964289C>A",0.383,skin,malignant_melanoma,,,,
288,271,D,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 267-271, ELM|MAPK docking motifs (DOC_MAPK_MEF2A_6), 267-274, ELM|MAPK docking motifs (DOC_MAPK_NFAT4_5), 267-275, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,,,,,,,,,,,,
289,272,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 267-274, ELM|MAPK docking motifs (DOC_MAPK_NFAT4_5), 267-275, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,,,,,,,,,,,,
290,273,F,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 267-274, ELM|MAPK docking motifs (DOC_MAPK_NFAT4_5), 267-275, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,,,,,,,,,,,,
291,274,M,T,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 267-274, ELM|MAPK docking motifs (DOC_MAPK_NFAT4_5), 267-275, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 274-282, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,"cBioPortal,COSMIC",kirc_tcga_pub,Renal Clear Cell Carcinoma,"hg19,19:964302-964302, hg38,19:964302-964302","hg19,19:g.964302T>C, hg38,19:g.964302T>C",0.264,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,,,
292,274,M,V,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_MEF2A_6), 267-274, ELM|MAPK docking motifs (DOC_MAPK_NFAT4_5), 267-275, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 274-282, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,19:964301-964301","hg19,19:g.964301A>G",0.311,,,,,,
293,275,L,,,,,,,,,,,,"MAPK docking motifs (DOC_MAPK_NFAT4_5), 267-275, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 274-282, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,,,,,,,,,,,,
294,276,Y,,P,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 276-279, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 276-279, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 274-282, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 276-279, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,,,,,,,,,,,,
295,277,V,M,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 276-279, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 276-279, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 274-282, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 276-279, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,"cBioPortal,COSMIC",sarc_tcga_pan_can_atlas_2018,Soft Tissue,"hg19,19:964310-964310, hg38,19:964310-964310","hg19,19:g.964310G>A, hg38,19:g.964310G>A",0.056,"lung, soft_tissue, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing, sarcoma",0.0000079699056363,,,
296,278,L,M,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 276-279, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 276-279, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 274-282, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 276-279, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,cBioPortal,"paad_tcga, paad_tcga_pan_can_atlas_2018",Pancreatic Adenocarcinoma,"hg19,19:964313-964313","hg19,19:g.964313C>A",0.454,,,,,,
297,279,V,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_PTP2), 276-279, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 276-279, ELM|Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 274-282, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 276-279, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,,,,,,,,,,,,
298,280,T,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 274-282, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,,,,,,,,,,,,
299,281,E,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 274-282, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 281-286, ELM|NES Nuclear Export Signal (TRG_NES_CRM1_1), 268-281, ELM",,,,,,,,,,,,,
300,282,K,,,,,,,,,,,,"Binding motif for UBA3 adenylation domain (LIG_UBA3_1), 274-282, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 281-286, ELM",,,,,,,,,,,,,
301,283,G,D,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 281-286, ELM",,"cBioPortal,COSMIC","difg_glass_2019, prad_tcga_pan_can_atlas_2018","Diffuse Glioma, Prostate Adenocarcinoma","hg19,19:964329-964329, hg38,19:964329-964329","hg19,19:g.964329G>A, hg38,19:g.964329G>A",0.943,prostate,"carcinoma, adenocarcinoma",,,,
302,284,G,S,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 281-286, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pub",Endometrial Carcinoma,"hg19,19:964331-964331, hg38,19:964331-964331","hg19,19:g.964331G>A, hg38,19:g.964331G>A",0.963,endometrium,"carcinoma, endometrioid_carcinoma",,,,
303,285,L,I,,,,,,,,,,,"GTPase-binding domain (GBD) ligand (LIG_GBD_Chelix_1), 285-293, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 281-286, ELM",,cBioPortal,"pcpg_tcga, pcpg_tcga_pub","Miscellaneous Neuroepithelial Tumor, Soft Tissue","hg19,19:964334-964334","hg19,19:g.964334C>A",0.325,,,,,,
304,286,V,,,,,,,,,,,,"GTPase-binding domain (GBD) ligand (LIG_GBD_Chelix_1), 285-293, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 281-286, ELM",,,,,,,,,,,,,
305,287,E,D,,,,,,,,,,,"GTPase-binding domain (GBD) ligand (LIG_GBD_Chelix_1), 285-293, ELM",,"cBioPortal,COSMIC","coad_cptac_2019, coadread_genentech","Colon Adenocarcinoma, Colorectal Adenocarcinoma","hg19,19:964342-964342, hg38,19:964342-964342","hg19,19:g.964342G>T, hg38,19:g.964342G>T",0.293,"large_intestine, colon","carcinoma, adenocarcinoma",,,,
306,288,V,,,,,,,,,,,,"GTPase-binding domain (GBD) ligand (LIG_GBD_Chelix_1), 285-293, ELM",,,,,,,,,,,,,
307,289,I,M,,,,,,,,,,,"GTPase-binding domain (GBD) ligand (LIG_GBD_Chelix_1), 285-293, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,19:964348-964348, hg38,19:964348-964348","hg19,19:g.964348C>G, hg38,19:g.964348C>G",0.409,breast,carcinoma,,,,
308,290,N,,,,,,,,,,,,"GTPase-binding domain (GBD) ligand (LIG_GBD_Chelix_1), 285-293, ELM",,,,,,,,,,,,,
309,291,K,E,,,,,,,,,,,"GTPase-binding domain (GBD) ligand (LIG_GBD_Chelix_1), 285-293, ELM",,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:964352-964352","hg19,19:g.964352A>G",0.413,,,,,,
310,291,K,R,,,,,,,,,,,"GTPase-binding domain (GBD) ligand (LIG_GBD_Chelix_1), 285-293, ELM",,COSMIC,,,"hg38,19:964353-964353","hg38,19:g.964353A>G",0.227,stomach,carcinoma,,,,
311,292,K,,,,,,,,,,,,"GTPase-binding domain (GBD) ligand (LIG_GBD_Chelix_1), 285-293, ELM",,,,,,,,,,,,,
312,293,L,,,,,,,,,,,,"GTPase-binding domain (GBD) ligand (LIG_GBD_Chelix_1), 285-293, ELM",,,,,,,,,,,,,
313,294,W,,,,,,,,,,,,,,,,,,,,,,,,,
314,295,R,C,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 295-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 295-306, ELM",,COSMIC,,,"hg38,19:964364-964364","hg38,19:g.964364C>T",0.518,stomach,carcinoma,,,,
315,296,E,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 295-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 295-306, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 296-306, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 296-302, ELM",,,,,,,,,,,,,
316,297,I,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 295-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 295-306, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 296-306, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 296-302, ELM",,,,,,,,,,,,,
317,298,T,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 295-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 295-306, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 296-306, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 296-302, ELM",,,,,,,,,,,,,
318,299,K,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 295-299, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 295-306, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 296-306, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 296-302, ELM",,,,,,,,,,,,,
319,300,G,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 295-306, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 296-306, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 296-302, ELM",,,,,,,,,,,,,
320,301,L,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 295-306, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 296-306, ELM|Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 301-304, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 296-302, ELM",,,,,,,,,,,,,
321,302,N,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 295-306, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 296-306, ELM|Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 301-304, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 296-302, ELM",,,,,,,,,,,,,
322,303,L,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 295-306, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 296-306, ELM|Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 301-304, ELM",,,,,,,,,,,,,
323,304,P,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 295-306, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 296-306, ELM|Calcineurin (PP2B)-docking motif LxvP (DOC_PP2B_LxvP_1), 301-304, ELM",,,,,,,,,,,,,
324,305,T,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 295-306, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 296-306, ELM",,,,,,,,,,,,,
325,306,S,,,,,,,,,,,,"Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 295-306, ELM|Cyclin N-terminal Domain Docking Motifs (DOC_CYCLIN_RxL_1), 296-306, ELM",,,,,,,,,,,,,
326,307,I,,,,,,,,,,,,,,,,,,,,,,,,,
327,308,T,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 308-312, ELM",,,,,,,,,,,,,
328,309,S,I,P,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 308-312, ELM",,COSMIC,,,"hg38,19:964407-964407","hg38,19:g.964407G>T",0.816,thyroid,carcinoma,,,,
329,310,A,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 308-312, ELM",,,,,,,,,,,,,
330,311,A,T,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 308-312, ELM",,COSMIC,,,"hg38,19:964412-964412","hg38,19:g.964412G>A",0.638,liver,"other, neoplasm",,,,
331,312,F,,,,,,,,,,,,"BRCT phosphopeptide ligands (LIG_BRCT_BRCA1_1), 308-312, ELM",,,,,,,,,,,,,
332,313,T,I,,,,,,,,,,,,,"cBioPortal,COSMIC",skcm_yale,Cutaneous Melanoma,"hg19,19:964419-964420, hg38,19:964419-964420","hg19,19:g.964419_964420delinsTT, hg38,19:g.964419_964420delinsTT",,skin,malignant_melanoma,,,,
333,314,L,,,,,,,,,,,,,,,,,,,,,,,,,
334,315,R,W,,,,,,,,,,,,,COSMIC,,,"hg38,19:964424-964424","hg38,19:g.964424C>T",0.796,endometrium,"carcinoma, endometrioid_carcinoma",,,,
335,316,T,S,,,,,,,,,,,,,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,19:964428-964428, hg38,19:964428-964428","hg19,19:g.964428C>G, hg38,19:g.964428C>G",0.310,cervix,"carcinoma, squamous_cell_carcinoma",,,,
336,317,Q,,,,,,,,,,,,,,,,,,,,,,,,,
337,318,Y,,,,,,,,,,,,,,,,,,,,,,,,,
338,319,M,,,,,,,,,,,,,,,,,,,,,,,,,
339,320,K,,,,,,,,,,,,,,,,,,,,,,,,,
340,321,Y,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 321-324, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 321-324, ELM",,,,,,,,,,,,,
341,322,L,M,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 321-324, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 321-324, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,19:964846-964846, hg38,19:964846-964846","hg19,19:g.964846C>A, hg38,19:g.964846C>A",0.698,endometrium,"carcinoma, endometrioid_carcinoma",,,,
342,323,Y,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 321-324, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 321-324, ELM",,,,,,,,,,,,,
343,324,P,,,,,,,,,,,,"Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_SRC), 321-324, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 321-324, ELM",,,,,,,,,,,,,
344,325,Y,,,,,,,,,,,,,,,,,,,,,,,,,
345,326,E,,,,,,,,,,,,,,,,,,,,,,,,,
346,327,C,R,,,,,,,,,,,,,"cBioPortal,COSMIC",difg_glass_2019,Diffuse Glioma,"hg19,19:964861-964861, hg38,19:964861-964861","hg19,19:g.964861T>C, hg38,19:g.964861T>C",0.668,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,
347,328,E,,,,,,,,,,,,,,,,,,,,,,,,,
348,329,K,,,,Ubq,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 329-331, ELM",,,,,,,,,,,,,
349,330,R,W,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 329-331, ELM",,"cBioPortal,COSMIC","stad_tcga_pan_can_atlas_2018, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Endometrial Carcinoma, Stomach Adenocarcinoma","hg19,19:964870-964870, hg38,19:964870-964870","hg19,19:g.964870C>T, hg38,19:g.964870C>T",0.482,"endometrium, stomach","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",0.0000399376971924,0.0000318918229366,,
350,331,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC1ET2_1), 329-331, ELM",,,,,,,,,,,,,
351,332,L,F,,,,,,,,,,,,,"cBioPortal,COSMIC",desm_broad_2015,Desmoplastic Melanoma,"hg19,19:964876-964876, hg38,19:964876-964876","hg19,19:g.964876C>T, hg38,19:g.964876C>T",0.371,"skin, forearm","malignant_melanoma, desmoplastic",,,,
352,333,S,N,,,,,,,,,,,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,19:964880-964880, hg38,19:964880-964880","hg19,19:g.964880G>A, hg38,19:g.964880G>A",0.374,skin,malignant_melanoma,,,,
353,334,N,,,,,,,,,,,,,,,,,,,,,,,,,
354,335,P,,,,,,,,,,,,,,,,,,,,,,,,,
355,336,N,S,,,,,,,,,,,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:964889-964889, hg38,19:964889-964889","hg19,19:g.964889A>G, hg38,19:g.964889A>G",0.097,skin,"carcinoma, basal_cell_carcinoma",0.0000199358861900,,,
356,337,E,,,,,,,,,,,,,,,,,,,,,,,,,
357,338,L,,,,,,,,,,,,,,,,,,,,,,,,,
358,339,Q,,,,,,,,,,,,,,,,,,,,,,,,,
359,340,A,,,,,,,,,,,,,,,,,,,,,,,,,
360,341,A,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 341-345, ELM",,,,,,,,,,,,,
361,342,I,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 341-345, ELM",,,,,,,,,,,,,
362,343,D,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 341-345, ELM",,,,,,,,,,,,,
363,344,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 341-345, ELM",,,,,,,,,,,,,
364,345,N,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 341-345, ELM",,,,,,,,,,,,,
365,346,R,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 346-348, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 346-352, ELM",,,,,,,,,,,,,
366,347,R,Q,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 346-348, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 346-352, ELM",,"cBioPortal,COSMIC","nhl_bcgsc_2011, nhl_bcgsc_2013",Non-Hodgkin Lymphoma,"hg19,19:964922-964922, hg38,19:964922-964922","hg19,19:g.964922G>A, hg38,19:g.964922G>A",0.450,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,,,
367,348,E,,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 346-348, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 346-352, ELM",,,,,,,,,,,,,
368,349,G,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_PC7_1), 346-352, ELM",,,,,,,,,,,,,
369,350,R,W,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 350-352, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 346-352, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 350-355, ELM|Phospholigands for MAGUK family Guanylate Kinase-like Domains (LIG_DLG_GKlike_1), 350-358, ELM",,"cBioPortal,COSMIC",ampca_bcm_2016,Ampullary Carcinoma,"hg19,19:964930-964930, hg38,19:964930-964930","hg19,19:g.964930C>T, hg38,19:g.964930C>T",0.320,"pancreas, ampulla_of_Vater","carcinoma, ductal_carcinoma",,,,
370,351,R,L,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 350-352, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 346-352, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 350-355, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 351-355, ELM|Phospholigands for MAGUK family Guanylate Kinase-like Domains (LIG_DLG_GKlike_1), 350-358, ELM",,cBioPortal,lihc_amc_prv,Hepatocellular Carcinoma,"hg19,19:964934-964934","hg19,19:g.964934G>T",0.506,,,,,,
371,352,Q,H,,,,,,,,,,,"NRD cleavage site (CLV_NRD_NRD_1), 350-352, ELM|PCSK cleavage site (CLV_PCSK_PC7_1), 346-352, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 350-355, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 351-355, ELM|Phospholigands for MAGUK family Guanylate Kinase-like Domains (LIG_DLG_GKlike_1), 350-358, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:964938-964938","hg19,19:g.964938G>C",0.204,,,,,,
372,353,S,,P,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 350-355, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 351-355, ELM|Phospholigands for MAGUK family Guanylate Kinase-like Domains (LIG_DLG_GKlike_1), 350-358, ELM",,,,,,,,,,,,,
373,354,F,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 350-355, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 351-355, ELM|Phospholigands for MAGUK family Guanylate Kinase-like Domains (LIG_DLG_GKlike_1), 350-358, ELM",,,,,,,,,,,,,
374,355,G,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 350-355, ELM|14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 351-355, ELM|Phospholigands for MAGUK family Guanylate Kinase-like Domains (LIG_DLG_GKlike_1), 350-358, ELM",,,,,,,,,,,,,
375,356,G,C,,,,,,,,,,,"Phospholigands for MAGUK family Guanylate Kinase-like Domains (LIG_DLG_GKlike_1), 350-358, ELM",,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,19:964948-964948","hg19,19:g.964948G>T",0.153,,,,,,
376,357,S,F,P,,,,,,,,,,"Phospholigands for MAGUK family Guanylate Kinase-like Domains (LIG_DLG_GKlike_1), 350-358, ELM",,"cBioPortal,COSMIC",brca_sanger,Invasive Breast Carcinoma,"hg19,19:964952-964952, hg38,19:964952-964952","hg19,19:g.964952C>T, hg38,19:g.964952C>T",0.228,breast,carcinoma,,,,
377,358,L,,,,,,,,,,,,"Phospholigands for MAGUK family Guanylate Kinase-like Domains (LIG_DLG_GKlike_1), 350-358, ELM",,,,,,,,,,,,,
378,359,F,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 359-364, ELM",,,,,,,,,,,,,
379,360,A,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 359-364, ELM",,,,,,,,,,,,,
380,361,Y,,P,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 359-364, ELM",,,,,,,,,,,,,
381,362,S,,P,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 359-364, ELM",,,,,,,,,,,,,
382,363,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 359-364, ELM",,,,,,,,,,,,,
383,364,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 359-364, ELM",,,,,,,,,,,,,
384,365,G,R,,,,,,,,,,,,,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma","hg19,19:964975-964975, hg38,19:964975-964975","hg19,19:g.964975G>A, hg38,19:g.964975G>A",0.269,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",0.0000119751874117,0.0000638243553740,,
385,365,G,V,,,,,,,,,,,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:964976-964976, hg38,19:964976-964976","hg19,19:g.964976G>T, hg38,19:g.964976G>T",0.313,skin,malignant_melanoma,,,,
386,366,A,,,,,,,,,,,,,,,,,,,,,,,,,
387,367,H,,,,,,,,,,,,,,,,,,,,,,,,,
388,368,G,C,,,,,,,,,,,,,"cBioPortal,COSMIC",mcl_idibips_2013,Mantle Cell Lymphoma,"hg19,19:964984-964984, hg38,19:964984-964984","hg19,19:g.964984G>T, hg38,19:g.964984G>T",0.129,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, mantle_cell_lymphoma",,,,
389,368,G,S,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:964984-964984","hg19,19:g.964984G>A",0.051,,,0.0000159745684870,,,
390,369,M,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 369-374, ELM",,,,,,,,,,,,,
391,370,L,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 369-374, ELM|SH3 ligand (LIG_SH3_3), 370-376, ELM",,,,,,,,,,,,,
392,371,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 369-374, ELM|SH3 ligand (LIG_SH3_3), 370-376, ELM",,,,,,,,,,,,,
393,372,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 369-374, ELM|SH3 ligand (LIG_SH3_3), 370-376, ELM",,,,,,,,,,,,,
394,373,P,S,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 369-374, ELM|SH3 ligand (LIG_SH3_3), 370-376, ELM",,"cBioPortal,COSMIC",desm_broad_2015,Desmoplastic Melanoma,"hg19,19:964999-964999, hg38,19:964999-964999","hg19,19:g.964999C>T, hg38,19:g.964999C>T",0.161,"skin, upper_arm","malignant_melanoma, desmoplastic",0.0000039975055565,0.0000956876754274,,
395,374,K,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 369-374, ELM|SH3 ligand (LIG_SH3_3), 370-376, ELM",,,,,,,,,,,,,
396,375,L,,,,,,,,,,,,"SH3 ligand (LIG_SH3_3), 370-376, ELM",,,,,,,,,,,,,
397,376,P,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 376-380, ELM|SH3 ligand (LIG_SH3_3), 370-376, ELM",,,,,,,,,,,,,
398,377,V,M,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 376-380, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:965011-965011, hg38,19:965011-965011","hg19,19:g.965011G>A, hg38,19:g.965011G>A",0.070,"large_intestine, large_intestine, rectum","carcinoma, adenocarcinoma",0.0000200187375383,,,
399,378,S,F,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 376-380, ELM",,cBioPortal,skcm_dfci_2015,Cutaneous Melanoma,"hg19,19:965015-965015","hg19,19:g.965015C>T",0.175,,,,,,
400,379,S,F,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 376-380, ELM",,"cBioPortal,COSMIC","mixed_allen_2018, pancan_pcawg_2020, skcm_mskcc_2014","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:965018-965018, hg38,19:965018-965018","hg19,19:g.965018C>T, hg38,19:g.965018C>T",0.096,liver,carcinoma,,,,
401,380,L,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 376-380, ELM",,,,,,,,,,,,,
402,381,G,,,,,,,,,,,,,,,,,,,,,,,,,
403,382,L,,,,,,,,,,,,,,,,,,,,,,,,,
404,383,A,,,,,,,,,,,,,,,,,,,,,,,,,
405,384,A,,,,,,,,,,,,,,,,,,,,,,,,,
406,385,S,,,,,,,,,,,,,,,,,,,,,,,,,
407,386,T,,,,,,,,,,,,,,,,,,,,,,,,,
408,387,N,,,,,,,,,,,,,,,,,,,,,,,,,
409,388,G,,,,,,,,,,,,,,,,,,,,,,,,,
410,389,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 389-394, ELM",,,,,,,,,,,,,
411,390,S,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 389-394, ELM",,,,,,,,,,,,,
412,391,I,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 389-394, ELM",,,,,,,,,,,,,
413,392,T,P,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 389-394, ELM",,cBioPortal,prad_su2c_2019,Prostate Adenocarcinoma,"hg19,19:965056-965056","hg19,19:g.965056A>C",0.053,,,0.0173301172893505,0.0001922091235264,,
414,393,P,L,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 389-394, ELM",,"cBioPortal,COSMIC","difg_glass_2019, mel_dfci_2019","Diffuse Glioma, Melanoma","hg19,19:965060-965060, hg38,19:965060-965060","hg19,19:g.965060C>T, hg38,19:g.965060C>T",0.174,large_intestine,"carcinoma, adenocarcinoma",,,,
415,393,P,S,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 389-394, ELM",,cBioPortal,"mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:965059-965059","hg19,19:g.965059C>T",0.046,,,,,,
416,394,A,T,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 389-394, ELM",,"cBioPortal,COSMIC","skcm_yale, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Cutaneous Melanoma, Endometrial Carcinoma","hg19,19:965062-965062, hg38,19:965062-965062","hg19,19:g.965062G>A, hg38,19:g.965062G>A",0.014,"endometrium, skin","carcinoma, endometrioid_carcinoma, malignant_melanoma",0.0000774315545811,0.0003190199706502,,
417,395,P,,,,,,,,,,,,,,,,,,,,,,,,,
418,396,K,,,,,,,,,,,,,,,,,,,,,,,,,
419,397,I,S,,,,,,,,,,,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:965072-965072, hg38,19:965072-965072","hg19,19:g.965072T>G, hg38,19:g.965072T>G",0.162,large_intestine,"carcinoma, adenocarcinoma",,,,
420,398,K,,,,,,,,Sumo,,,,,,,,,,,,,,,,,
421,399,K,,,,,,,,,,,,,,,,,,,,,,,,,
422,400,E,,,,,,,,,,,,,,,,,,,,,,,,,
423,401,E,,,,,,,,,,,,,,,,,,,,,,,,,
424,402,D,N,,,,,,,,,,,,,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,19:966577-966577","hg19,19:g.966577G>A",0.094,,,,,,
425,403,S,,,,,,,,,,,,,,,,,,,,,,,,,
426,404,A,V,,,,,,,,,,,,,COSMIC,,,"hg38,19:966584-966584","hg38,19:g.966584C>T",0.098,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",0.0120076985797448,0.0140359831568202,,
427,405,I,,,,,,,,,,,,,,,,,,,,,,,,,
428,406,P,T,,,,,,,,,,,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,19:966589-966589","hg19,19:g.966589C>A",0.080,,,0.0000045754445044,,,
429,407,I,,,,,,,,,,,,,,,,,,,,,,,,,
430,408,T,,P,,,,,,,,,,,,,,,,,,,,,,,
431,409,V,,,,,,,,,,,,,,,,,,,,,,,,,
432,410,P,H,,,,,,,,,,,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:966602-966602, hg38,19:966602-966602","hg19,19:g.966602C>A, hg38,19:g.966602C>A",0.265,skin,malignant_melanoma,,,,
433,410,P,S,,,,,,,,,,,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,19:966601-966601","hg19,19:g.966601C>T",0.084,,,,,,
434,411,G,,,,,,,,,,,,,,,,,,,,,,,,,
435,412,R,C,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 412-418, ELM",,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,19:966607-966607","hg19,19:g.966607C>T",0.216,,,0.0000428908428051,0.0000956510649152,,
436,412,R,L,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 412-418, ELM",,"cBioPortal,COSMIC","lihc_tcga, lihc_tcga_pan_can_atlas_2018",Hepatocellular Carcinoma,"hg19,19:966608-966608, hg38,19:966608-966608","hg19,19:g.966608G>T, hg38,19:g.966608G>T",0.239,liver,"carcinoma, hepatocellular_carcinoma, other, neoplasm",,,,
437,413,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 412-418, ELM",,,,,,,,,,,,,
438,414,P,L,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 412-418, ELM|CtBP ligand motif (LIG_CtBP_PxDLS_1), 414-418, ELM",,COSMIC,,,"hg38,19:966614-966614","hg38,19:g.966614C>T",0.175,"skin, shoulder","malignant_melanoma, malignant_melanoma, nodular",,,,
439,415,V,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 412-418, ELM|CtBP ligand motif (LIG_CtBP_PxDLS_1), 414-418, ELM",,,,,,,,,,,,,
440,416,S,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 412-418, ELM|CtBP ligand motif (LIG_CtBP_PxDLS_1), 414-418, ELM",,,,,,,,,,,,,
441,417,L,,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 412-418, ELM|CtBP ligand motif (LIG_CtBP_PxDLS_1), 414-418, ELM",,,,,,,,,,,,,
442,418,A,V,,,,,,,,,,,"14-3-3 binding phosphopeptide motif (LIG_14-3-3_CanoR_1), 412-418, ELM|CtBP ligand motif (LIG_CtBP_PxDLS_1), 414-418, ELM",,"cBioPortal,COSMIC","prad_p1000, prad_su2c_2015, prad_su2c_2019",Prostate Adenocarcinoma,"hg19,19:966626-966626, hg38,19:966626-966626","hg19,19:g.966626C>T, hg38,19:g.966626C>T",0.215,prostate,carcinoma,0.0000456333073362,,,
443,419,G,C,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,19:966628-966628, hg38,19:966628-966628","hg19,19:g.966628G>T, hg38,19:g.966628G>T",0.340,lung,"carcinoma, adenocarcinoma",,,,
444,419,G,V,,,,,,,,,,,,,COSMIC,,,"hg38,19:966629-966629","hg38,19:g.966629G>T",0.160,oesophagus,"carcinoma, squamous_cell_carcinoma",,,,
445,420,H,,,,,,,,,,,,,,,,,,,,,,,,,
446,421,P,L,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:966635-966635","hg19,19:g.966635C>T",0.130,,,,,,
447,422,V,,,,,,,,,,,,,,,,,,,,,,,,,
448,423,V,,,,,,,,,,,,,,,,,,,,,,,,,
449,424,A,E,,,,,,,,,,,,,COSMIC,,,"hg38,19:966644-966644","hg38,19:g.966644C>A",0.122,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,,,
450,424,A,T,,,,,,,,,,,,,COSMIC,,,"hg38,19:966643-966643","hg38,19:g.966643G>A",0.086,"oesophagus, middle_third","carcinoma, squamous_cell_carcinoma",,,,
451,424,A,V,,,,,,,,,,,,,"cBioPortal,COSMIC",nccrcc_genentech_2014,Renal Non-Clear Cell Carcinoma,"hg19,19:966644-966644, hg38,19:966644-966644","hg19,19:g.966644C>T, hg38,19:g.966644C>T",0.079,kidney,"carcinoma, papillary_renal_cell_carcinoma",,,,
452,425,A,,,,,,,,,,,,,,,,,,,,,,,,,
453,426,Q,,,,,,,,,,,,,,,,,,,,,,,,,
454,427,A,,,,,,,,,,,,,,,,,,,,,,,,,
455,428,A,,,,,,,,,,,,,,,,,,,,,,,,,
456,429,A,T,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:966658-966658","hg19,19:g.966658G>A",0.139,,,0.0000371673521978,,,
457,430,V,,,,,,,,,,,,,,,,,,,,,,,,,
458,431,Q,R,,,,,,,,,,,,,cBioPortal,coad_silu_2022,Colon Adenocarcinoma,"hg19,19:966665-966665","hg19,19:g.966665A>G",0.076,,,,,,
459,432,A,T,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:966667-966667","hg19,19:g.966667G>A",0.118,,,0.0000701615366202,,,
460,433,A,,,,,,,,,,,,,,,,,,,,,,,,,
461,434,A,D,,,,,,,,,,,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:966674-966674","hg19,19:g.966674C>A",0.201,,,,,,
462,435,A,T,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:966676-966676, hg38,19:966676-966676","hg19,19:g.966676G>A, hg38,19:g.966676G>A",0.173,"large_intestine, large_intestine, caecum, large_intestine, colon","carcinoma, adenocarcinoma",0.0000123730728939,0.0000638121370685,,
463,436,Q,,,,,,,,,,,,,,,,,,,,,,,,,
464,437,A,,,,,,,,,,,,,,,,,,,,,,,,,
465,438,A,,,,,,,,,,,,,,,,,,,,,,,,,
466,439,V,M,,,,,,,,,,,,,COSMIC,,,"hg38,19:966688-966688","hg38,19:g.966688G>A",0.058,lung,"carcinoma, adenocarcinoma",0.0000082231432143,,,
467,440,A,,,,,,,,,,,,,,,,,,,,,,,,,
468,441,A,T,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:966694-966694","hg19,19:g.966694G>A",0.114,,,,,,
469,442,Q,,,,,,,,,,,,,,,,,,,,,,,,,
470,443,A,,,,,,,,,,,,,,,,,,,,,,,,,
471,444,A,,,,,,,,,,,,,,,,,,,,,,,,,
472,445,A,S,,,,,,,,,,,,,COSMIC,,,"hg38,19:966706-966706","hg38,19:g.966706G>T",0.093,liver,"other, neoplasm",,,,
473,446,L,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 446-452, ELM",,,,,,,,,,,,,
474,447,E,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 446-452, ELM",,,,,,,,,,,,,
475,448,Q,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 446-452, ELM",,,,,,,,,,,,,
476,449,L,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 446-452, ELM",,,,,,,,,,,,,
477,450,R,Q,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 446-452, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, coadread_dfci_2016","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,19:966722-966722, hg38,19:966722-966722","hg19,19:g.966722G>A, hg38,19:g.966722G>A",0.235,"large_intestine, large_intestine, colon, transverse","carcinoma, adenocarcinoma",0.0000243500564110,,,
478,450,R,W,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 446-452, ELM",,cBioPortal,"ccle_broad_2019, gbm_tcga_pan_can_atlas_2018","Glioblastoma Multiforme, Mixed Cancer Types","hg19,19:966721-966721","hg19,19:g.966721C>T",0.318,,,0.0000243902439024,,,
479,451,E,,,,,,,,,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 446-452, ELM",,,,,,,,,,,,,
480,452,K,,,,Ubq,,,,Sumo,,,,"PP2A holoenzyme B56-docking site (DOC_PP2A_B56_1), 446-452, ELM",,,,,,,,,,,,,
481,453,L,,,,,,,,,,,,,,,,,,,,,,,,,
482,454,E,,,,,,,,,,,,,,,,,,,,,,,,,
483,455,S,,,,,,,,,,,,,,,,,,,,,,,,,
484,456,A,V,,,,,,,,,,,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:966740-966740, hg38,19:966740-966740","hg19,19:g.966740C>T, hg38,19:g.966740C>T",0.137,"endometrium, stomach","carcinoma, carcinoma, endometrioid_carcinoma",,,,
485,457,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC",pog570_bcgsc_2020,Mixed Cancer Types,"hg19,19:966742-966742, hg38,19:966742-966742","hg19,19:g.966742G>A, hg38,19:g.966742G>A",0.273,"urinary_tract, bladder",carcinoma,,,,
486,458,P,T,,,,,,,,,,,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:966745-966745, hg38,19:966745-966745","hg19,19:g.966745C>A, hg38,19:g.966745C>A",0.280,stomach,"carcinoma, adenocarcinoma",,,,
487,459,P,A,,,,,,,,,,,,,COSMIC,,,"hg38,19:966748-966748","hg38,19:g.966748C>G",0.223,"upper_aerodigestive_tract, mouth",carcinoma,,,,
488,459,P,L,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
489,460,E,,,,,,,,,,,,,,,,,,,,,,,,,
490,461,K,N,,,,,,,,,,,,,COSMIC,,,"hg38,19:966756-966756","hg38,19:g.966756G>T",0.205,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,,,
491,462,K,,,,,,,,Sumo,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 462-466, ELM",,,,,,,,,,,,,
492,463,M,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 462-466, ELM",,,,,,,,,,,,,
493,464,A,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 462-466, ELM",,,,,,,,,,,,,
494,465,L,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 462-466, ELM",,,,,,,,,,,,,
495,466,V,,,,,,,,,,,,"PCSK cleavage site (CLV_PCSK_SKI1_1), 462-466, ELM",,,,,,,,,,,,,
496,467,A,V,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:966773-966774","hg19,19:g.966773_966774delinsTT",,,,,,,
497,468,D,,,,,,,,,,,,,,,,,,,,,,,,,
498,469,E,G,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 469-474, ELM",,"cBioPortal,COSMIC",esca_broad,Esophageal Adenocarcinoma,"hg19,19:966779-966779, hg38,19:966779-966779","hg19,19:g.966779A>G, hg38,19:g.966779A>G",0.393,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",,,,
499,470,Q,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 469-474, ELM",,,,,,,,,,,,,
500,471,Q,,,,,,,,,,,,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 469-474, ELM",,,,,,,,,,,,,
501,472,R,Q,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 472-476, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 469-474, ELM",,Manual annotations from clinvar.csv,,,,,,,,,,,
502,473,L,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 472-476, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 469-474, ELM",,,,,,,,,,,,,
503,474,M,T,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 472-476, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals (TRG_DiLeu_BaEn_1), 469-474, ELM",,cBioPortal,luad_oncosg_2020,Lung Adenocarcinoma,"hg19,19:966794-966794","hg19,19:g.966794T>C",0.160,,,,,,
504,475,Q,,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 472-476, ELM",,,,,,,,,,,,,
505,476,R,C,,,,,,,,,,,"Motif which binds to the MATH domain of the TRAF4 K63 E3 ligase (LIG_TRAF4_MATH_1), 472-476, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,19:966799-966799, hg38,19:966799-966799","hg19,19:g.966799C>T, hg38,19:g.966799C>T",0.232,"large_intestine, colon","carcinoma, adenocarcinoma",0.0000399007269912,,,
506,477,A,,,,,,,,,,,,,,,,,,,,,,,,,
507,478,L,,,,,,,,,,,,,,,,,,,,,,,,,
508,479,Q,R,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
509,480,Q,,,,,,,,,,,,,,,,,,,,,,,,,
510,481,N,,,,,,,,,,,,,,,,,,,,,,,,,
511,482,F,,,,,,,,,,,,,,,,,,,,,,,,,
512,483,L,,,,,,,,,,,,,,,,,,,,,,,,,
513,484,A,,,,,,,,,,,,,,,,,,,,,,,,,
514,485,M,T,,,,,,,,,,,,,COSMIC,,,"hg38,19:966827-966827","hg38,19:g.966827T>C",0.321,stomach,"carcinoma, adenocarcinoma",,,,
515,486,A,,,,,,,,,,,,,,,,,,,,,,,,,
516,487,A,S,,,,,,,,,,,,,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,19:966832-966832","hg19,19:g.966832G>T",0.074,,,,,,
517,487,A,V,,,,,,,,,,,,,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,19:966833-966833","hg19,19:g.966833C>T",0.115,,,,,,
518,488,Q,,,,,,,,,,,,,,,,,,,,,,,,,
519,489,L,,,,,,,,,,,,,,,,,,,,,,,,,
520,490,P,,,,,,,,,,,,,,,,,,,,,,,,,
521,491,M,I,,,,,,,,,,,,,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,19:966846-966846, hg38,19:966846-966846","hg19,19:g.966846G>C, hg38,19:g.966846G>A, hg38,19:g.966846G>C",0.171,"cervix, haematopoietic_and_lymphoid_tissue","carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, plasma_cell_myeloma",0.0000040165159134,,,
522,492,S,,P,,,,,,,,,,,,,,,,,,,,,,,
523,493,I,,,,,,,,,,,,,,,,,,,,,,,,,
524,494,R,Q,,,,,,,,,,,,,COSMIC,,,"hg38,19:966854-966854","hg38,19:g.966854G>A",0.162,"large_intestine, thyroid","carcinoma, carcinoma, adenocarcinoma",0.0003749909276388,0.0012419591108847,,
525,494,R,W,,,,,,,,,,,,,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:966853-966853","hg19,19:g.966853C>T",0.258,,,0.0000120959938069,,,
526,495,I,,,,,,,,,,,,,,,,,,,,,,,,,
527,496,N,I,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:966860-966860","hg19,19:g.966860A>T",0.181,,,,,,
528,496,N,K,,,,,,,,,,,,,COSMIC,,,"hg38,19:966861-966861","hg38,19:g.966861C>A",0.179,thyroid,carcinoma,,,,
529,497,S,,,,,,,,,,,,,,,,,,,,,,,,,
530,498,Q,,,,,,,,,,,,,,,,,,,,,,,,,
531,499,A,T,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 499-503, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,19:966868-966868, hg38,19:966868-966868","hg19,19:g.966868G>A, hg38,19:g.966868G>A",0.165,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,,,
532,500,S,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 499-503, ELM",,,,,,,,,,,,,
533,501,E,,,,,,,,,,,,"USP7 binding motif (DOC_USP7_MATH_1), 499-503, ELM",,,,,,,,,,,,,
534,502,S,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 502-506, ELM|USP7 binding motif (DOC_USP7_MATH_1), 499-503, ELM",,,,,,,,,,,,,
535,503,R,C,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 502-506, ELM|USP7 binding motif (DOC_USP7_MATH_1), 499-503, ELM",,COSMIC,,,"hg38,19:968416-968416","hg38,19:g.968416C>T",0.357,large_intestine,"carcinoma, adenocarcinoma",0.0000159309235156,0.0000319182891797,,
536,504,Q,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 502-506, ELM",,,,,,,,,,,,,
537,505,D,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 502-506, ELM",,,,,,,,,,,,,
538,506,S,,,,,,,,,,,,"Caspase cleavage motif (CLV_C14_Caspase3-7), 502-506, ELM",,,,,,,,,,,,,
539,507,A,,,,,,,,,,,,,,,,,,,,,,,,,
540,508,V,,,,,,,,,,,,,,,,,,,,,,,,,
541,509,N,,,,,,,,,,,,,,,,,,,,,,,,,
542,510,L,,,,,,,,,,,,,,,,,,,,,,,,,
543,511,T,M,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
544,512,G,,,,,,,,,,,,,,,,,,,,,,,,,
545,513,T,I,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:968447-968447","hg19,19:g.968447C>T",0.126,,,,,,
546,514,N,I,,,,,,,,,,,,,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,19:968450-968450, hg38,19:968450-968450","hg19,19:g.968450A>T, hg38,19:g.968450A>T",0.251,lung,"carcinoma, adenocarcinoma",,,,
547,514,N,S,,,,,,,,,,,,,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,19:968450-968450","hg38,19:g.968450A>G",0.124,lung,"carcinoma, adenocarcinoma",,,,
548,515,G,D,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:968453-968453, hg38,19:968453-968453","hg19,19:g.968453G>A, hg38,19:g.968453G>A",0.515,large_intestine,"carcinoma, adenocarcinoma",,0.0000318775900542,,
549,516,S,,,,,,,,,,,,,,,,,,,,,,,,,
550,517,N,,,,,,,,,,,,,,,,,,,,,,,,,
551,518,S,N,,,,,,,,,,,,,"cBioPortal,COSMIC","stad_oncosg_2018, stad_pfizer_uhongkong, stad_uhongkong",Stomach Adenocarcinoma,"hg19,19:968462-968462, hg38,19:968462-968462","hg19,19:g.968462G>A, hg38,19:g.968462G>A",0.349,stomach,"carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma",,,,
552,519,I,,,,,,,,,,,,,,,,,,,,,,,,,
553,520,S,,,,,,,,,,,,,,,,,,,,,,,,,
554,521,M,V,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:968470-968470","hg19,19:g.968470A>G",0.251,,,0.0000039796876741,,,
555,522,S,,,,,,,,,,,,,,,,,,,,,,,,,
556,523,V,A,,,,,,,,,,,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:968477-968477","hg19,19:g.968477T>C",0.295,,,,,,
557,523,V,M,,,,,,,,,,,,,Manual annotations from clinvar.csv,,,,,,,,,,,
558,524,E,K,,,,,,,,,,,,,"cBioPortal,COSMIC","pancan_pcawg_2020, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:968479-968479, hg38,19:968479-968479","hg19,19:g.968479G>A, hg38,19:g.968479G>A",0.532,skin,malignant_melanoma,,,,
559,525,I,,,,,,,,,,,,,,,,,,,,,,,,,
560,526,N,,,,,,,,,,,,,,,,,,,,,,,,,
561,527,G,C,,,,,,,,,,,,,COSMIC,,,"hg38,19:968488-968488","hg38,19:g.968488G>T",0.700,thyroid,carcinoma,,,,
562,527,G,S,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:968488-968488, hg38,19:968488-968488","hg19,19:g.968488G>A, hg38,19:g.968488G>A",0.651,large_intestine,"carcinoma, adenocarcinoma",0.0000119489540682,,,
563,528,I,,,,,,,,,,,,"Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 528-533, ELM",,,,,,,,,,,,,
564,529,M,I,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 529-535, ELM|Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 528-533, ELM",,COSMIC,,,"hg38,19:968496-968496","hg38,19:g.968496G>C",0.054,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,,,
565,529,M,V,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 529-535, ELM|Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 528-533, ELM",,"cBioPortal,COSMIC",tet_nci_2014,Thymic Epithelial Tumor,"hg19,19:968494-968494, hg38,19:968494-968494","hg19,19:g.968494A>G, hg38,19:g.968494A>G",0.011,thymus,"thymic_carcinoma, undifferentiated_carcinoma",0.0000039845399849,,,
566,530,Y,D,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 529-535, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 530-534, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 530-533, ELM|Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 528-533, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 530-533, ELM",,"cBioPortal,COSMIC","ov_tcga, ov_tcga_pub",High-Grade Serous Ovarian Cancer,"hg19,19:968497-968497, hg38,19:968497-968497","hg19,19:g.968497T>G, hg38,19:g.968497T>G",0.578,ovary,"carcinoma, serous_carcinoma",,,,
567,531,T,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 529-535, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 530-534, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 530-533, ELM|Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 528-533, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 530-533, ELM",,,,,,,,,,,,,
568,532,G,R,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 529-535, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 530-534, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 530-533, ELM|Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 528-533, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 530-533, ELM",,cBioPortal,skcm_broad,Cutaneous Melanoma,"hg19,19:968503-968503","hg19,19:g.968503G>A",0.717,,,,,,
569,533,V,F,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 529-535, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 530-534, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_STAT5), 530-533, ELM|Immunoreceptor tyrosine-based motif (LIG_TYR_ITIM), 528-533, ELM|Y-based sorting signal (TRG_ENDOCYTIC_2), 530-533, ELM",,COSMIC,,,"hg38,19:971880-971880","hg38,19:g.971880G>T",0.275,liver,"other, neoplasm",,,,
570,534,L,,,,,,,,,,,,"FHA phosphopeptide ligands (LIG_FHA_1), 529-535, ELM|Phosphotyrosine ligands bound by SH2 domains (LIG_SH2_CRK), 530-534, ELM",,,,,,,,,,,,,
571,535,F,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 535-538, ELM|FHA phosphopeptide ligands (LIG_FHA_1), 529-535, ELM|SH3 ligand (LIG_SH3_3), 535-541, ELM",,,,,,,,,,,,,
572,536,A,V,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 535-538, ELM|SH3 ligand (LIG_SH3_3), 535-541, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:971890-971890, hg38,19:971890-971890","hg19,19:g.971890C>T, hg38,19:g.971890C>T",0.243,endometrium,"carcinoma, endometrioid_carcinoma",,,,
573,537,Q,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 535-538, ELM|SH3 ligand (LIG_SH3_3), 535-541, ELM",,,,,,,,,,,,,
574,538,P,,,,,,,,,,,,"PP4 EVH1-binding docking motifs (DOC_PP4_FxxP_1), 535-538, ELM|SH3 ligand (LIG_SH3_3), 535-541, ELM",,,,,,,,,,,,,
575,539,P,Q,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 539-544, ELM|SH3 ligand (LIG_SH3_3), 535-541, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:971899-971899","hg19,19:g.971899C>A",0.167,,,0.0000042593428686,,,
576,540,A,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 539-544, ELM|SH3 ligand (LIG_SH3_3), 535-541, ELM",,,,,,,,,,,,,
577,541,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 539-544, ELM|SH3 ligand (LIG_SH3_3), 535-541, ELM",,,,,,,,,,,,,
578,542,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 539-544, ELM",,,,,,,,,,,,,
579,543,P,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 539-544, ELM",,,,,,,,,,,,,
580,544,T,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 539-544, ELM",,,,,,,,,,,,,
581,545,S,,,,,,,,,,,,,,,,,,,,,,,,,
582,546,A,,,,,,,,,,,,,,,,,,,,,,,,,
583,547,P,L,,,,,,,,,,,,,"cBioPortal,COSMIC","bcc_unige_2016, ccle_broad_2019, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Basal Cell Carcinoma, Cutaneous Melanoma, Mixed Cancer Types","hg19,19:971923-971923, hg38,19:971923-971923","hg19,19:g.971923C>T, hg38,19:g.971923C>T",0.040,skin,"carcinoma, basal_cell_carcinoma, malignant_melanoma",,,,
584,547,P,S,,,,,,,,,,,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018",Cutaneous Melanoma,"hg19,19:971922-971922, hg38,19:971922-971922","hg19,19:g.971922C>T, hg38,19:g.971922C>T",0.017,skin,malignant_melanoma,0.0000042261497240,,,
585,548,N,K,,,,,,,,,,,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:971927-971927, hg38,19:971927-971927","hg19,19:g.971927C>G, hg38,19:g.971927C>G",0.059,stomach,"carcinoma, adenocarcinoma",,,,
586,549,K,N,,,,,,,,,,,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:971930-971930, hg38,19:971930-971930","hg19,19:g.971930A>T, hg38,19:g.971930A>T",0.134,lung,"carcinoma, non_small_cell_carcinoma",,,,
587,550,G,,,,,,,,,,,,,,,,,,,,,,,,,
588,551,G,C,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:971934-971934","hg19,19:g.971934G>T",0.142,,,,0.0000642384531380,,
589,551,G,S,,,,,,,,,,,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:971934-971934","hg19,19:g.971934G>A",0.033,,,,,,
590,552,G,,,,,,,,,,,,,,,,,,,,,,,,,
591,553,G,S,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:971940-971940","hg19,19:g.971940G>A",0.025,,,0.0000393924804132,0.0000319631784185,,
592,554,G,R,,,,,,,,,,,,,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub",Head and Neck Squamous Cell Carcinoma,"hg19,19:971943-971943, hg38,19:971943-971943","hg19,19:g.971943G>C, hg38,19:g.971943G>C",0.034,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,,,
593,555,G,S,,,,,,,,,,,,,"cBioPortal,COSMIC","ccle_broad_2019, coadread_dfci_2016, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,19:971946-971946, hg38,19:971946-971946","hg19,19:g.971946G>A, hg38,19:g.971946G>A",0.003,"endometrium, large_intestine, large_intestine, colon, transverse, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",0.0000393098929897,0.0000319713536671,,
594,556,G,S,,,,,,,,,,,,,"cBioPortal,COSMIC","mds_mskcc_2020, mixed_pipseq_2017","Mixed Cancer Types, Myelodysplastic Syndromes","hg19,19:971949-971949, hg38,19:971949-971949","hg19,19:g.971949G>A, hg38,19:g.971949G>A",0.020,"large_intestine, caecum, large_intestine, colon, liver, lung, thyroid","carcinoma, carcinoma, adenocarcinoma, other, neoplasm",0.7771939019026138,0.7821686436307375,,
595,557,S,G,,,,,,,,,,,,,"cBioPortal,COSMIC","ccle_broad_2019, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,19:971952-971952, hg38,19:971952-971952","hg19,19:g.971952A>G, hg38,19:g.971952A>G",0.035,"endometrium, large_intestine, large_intestine, colon, ascending, large_intestine, colon, transverse, stomach","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, intestinal_adenocarcinoma",0.0000301062319900,,,
596,558,S,N,,,,,,,,,,,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:971956-971956","hg19,19:g.971956G>A",0.118,,,,,,
597,559,S,N,,,,,,,,,,,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:971959-971959, hg38,19:971959-971959","hg19,19:g.971959G>A, hg38,19:g.971959G>A",0.040,large_intestine,"carcinoma, adenocarcinoma",,,,
598,560,N,,,,,,,,,,,,,,,,,,,,,,,,,
599,561,A,,,,,,,,,,,,,,,,,,,,,,,,,
600,562,G,,,,,,,,,,,,,,,,,,,,,,,,,
601,563,G,S,,,,,,,,,,,,,"cBioPortal,COSMIC","coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,19:971970-971970, hg38,19:971970-971970","hg19,19:g.971970G>A, hg38,19:g.971970G>A",0.006,"large_intestine, caecum","carcinoma, adenocarcinoma",0.0000298917917140,0.0000318877551020,,
602,564,R,,,,,,,,,,,,,,,,,,,,,,,,,
603,565,G,,,,,,,,,,,,,,,,,,,,,,,,,
604,566,G,E,,,,,,,,,,,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:971980-971980, hg38,19:971980-971980","hg19,19:g.971980G>A, hg38,19:g.971980G>A",0.071,"skin, ear",malignant_melanoma,,,,
605,566,G,R,,,,,,,,,,,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:971979-971979, hg38,19:971979-971979","hg19,19:g.971979G>A, hg38,19:g.971979G>A",0.060,skin,"carcinoma, basal_cell_carcinoma",0.0000000000000000,,,
606,567,N,,,,,,,,,,,,,,,,,,,,,,,,,
607,568,T,,P,,,,,,,,,,,,,,,,,,,,,,,
608,569,G,E,,,,,,,,,,,,,COSMIC,,,"hg38,19:971989-971989","hg38,19:g.971989G>A",0.112,"biliary_tract, bile_duct",carcinoma,,,,
609,570,T,,,,,,,,,,,,,,,,,,,,,,,,,
610,571,S,,,,,,,,,,,,,,,,,,,,,,,,,
611,572,G,S,,,,,,,,,,,,,"cBioPortal,COSMIC",pptc_2019,Mixed Cancer Types,"hg19,19:971997-971997, hg38,19:971997-971997","hg19,19:g.971997G>A, hg38,19:g.971997G>A",0.029,large_intestine,"carcinoma, adenocarcinoma",0.0000394266489101,,,
612,573,G,,,,,,,,,,,,,,,,,,,,,,,,,
613,574,Q,,,,,,,,,,,,,,,,,,,,,,,,,
614,575,A,,,,,,,,,,,,,,,,,,,,,,,,,
615,576,G,E,,,,,,,,,,,,,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:972010-972010","hg19,19:g.972010G>A",0.220,,,0.0000044510121602,0.0000319938571794,,
616,577,P,S,,,,,,,,,,,,,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:972012-972012","hg19,19:g.972012C>T",0.052,,,0.0000044570430194,,,
617,578,A,V,,,,,,,,,,,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:972016-972016","hg19,19:g.972016C>T",0.119,,,0.0000453650525781,,,
618,579,G,,,,,,,,,,,,"WW domain ligands (DOC_WW_Pin1_4), 579-584, ELM",,,,,,,,,,,,,
619,580,L,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 580-586, ELM|Cks1 ligand (DOC_CKS1_1), 580-585, ELM|WW domain ligands (DOC_WW_Pin1_4), 579-584, ELM",,,,,,,,,,,,,
620,581,S,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 580-586, ELM|Cks1 ligand (DOC_CKS1_1), 580-585, ELM|WW domain ligands (DOC_WW_Pin1_4), 579-584, ELM",,,,,,,,,,,,,
621,582,T,,P,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 580-586, ELM|Cks1 ligand (DOC_CKS1_1), 580-585, ELM|WW domain ligands (DOC_WW_Pin1_4), 579-584, ELM",,,,,,,,,,,,,
622,583,P,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 580-586, ELM|SPOP SBC docking motif (DEG_SPOP_SBC_1), 583-587, ELM|Cks1 ligand (DOC_CKS1_1), 580-585, ELM|USP7 binding motif (DOC_USP7_MATH_1), 583-587, ELM|WW domain ligands (DOC_WW_Pin1_4), 579-584, ELM",,,,,,,,,,,,,
623,584,S,,P,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 580-586, ELM|SPOP SBC docking motif (DEG_SPOP_SBC_1), 583-587, ELM|Cks1 ligand (DOC_CKS1_1), 580-585, ELM|USP7 binding motif (DOC_USP7_MATH_1), 583-587, ELM|WW domain ligands (DOC_WW_Pin1_4), 579-584, ELM",,,,,,,,,,,,,
624,585,T,,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 580-586, ELM|SPOP SBC docking motif (DEG_SPOP_SBC_1), 583-587, ELM|Cks1 ligand (DOC_CKS1_1), 580-585, ELM|USP7 binding motif (DOC_USP7_MATH_1), 583-587, ELM",,,,,,,,,,,,,
625,586,S,F,,,,,,,,,,,"SCF ubiquitin ligase binding Phosphodegrons (DEG_SCF_FBW7_1), 580-586, ELM|SPOP SBC docking motif (DEG_SPOP_SBC_1), 583-587, ELM|USP7 binding motif (DOC_USP7_MATH_1), 583-587, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:972040-972040","hg19,19:g.972040C>T",0.206,,,,,,
626,587,T,,,,,,,,,,,,"SPOP SBC docking motif (DEG_SPOP_SBC_1), 583-587, ELM|USP7 binding motif (DOC_USP7_MATH_1), 583-587, ELM",,,,,,,,,,,,,
627,588,S,,,,,,,,,,,,,,,,,,,,,,,,,
628,589,N,,,,,,,,,,,,,,,,,,,,,,,,,
629,590,N,,,,,,,,,,,,,,,,,,,,,,,,,
630,591,S,L,P,,,,,,,,,,,,"cBioPortal,COSMIC","sarc_tcga, sarc_tcga_pan_can_atlas_2018",Soft Tissue,"hg19,19:972055-972055, hg38,19:972055-972055","hg19,19:g.972055C>T, hg38,19:g.972055C>T",0.126,soft_tissue,sarcoma,0.0000000000000000,,,
631,592,L,,,,,,,,,,,,,,,,,,,,,,,,,
632,593,P,,,,,,,,,,,,,,,,,,,,,,,,,
